Care Needed With Plain Language Summaries Of EU Study Results
Layperson Summaries Will Be Mandatory Under The New Clinical Trial Regulation
Executive Summary
The EU will make it mandatory for clinical trial sponsors to prepare layperson summaries of their study results. Industry practices around content presentation, translation and dissemination of these documents will be keenly watched.
You may also be interested in...
Here At Last: A New Era For Clinical Trials In The EU
A long-awaited regulation introduces major changes in the way that clinical trials are conducted across the EU, including a single application portal and new trial transparency requirements.
EU Offers ‘Timely And Helpful’ Advice On Summarizing Trial Results For Laypersons
With around three months left for the EU Clinical Trials Regulation to fully kick in, the European Commission has finalized much-awaited guidance offering practical insights into how companies can comply with new transparency requirements mandated under the legislation.
Philippines Considers Regulatory Reliance To Speed Up Evaluating Trial Applications
The Philippines FDA is looking to leverage the work conducted by “stringent” regulators when it comes to reviewing certain clinical trial applications.